<?xml version="1.0" encoding="UTF-8"?>
<p id="p0020">B19V DNA prevalence varying from 0.2 to 1.9% has been reported among blood donors, and the concentrations determined are frequently &lt;10
 <sup>4</sup> viral genome UI/ml [
 <xref rid="bib18" ref-type="bibr">18</xref>, 
 <xref rid="bib19" ref-type="bibr">19</xref>]. However, individuals with higher viral loads have also been detected [
 <xref rid="bib2" ref-type="bibr">2</xref>, 
 <xref rid="bib19" ref-type="bibr">19</xref>, 
 <xref rid="bib20" ref-type="bibr">20</xref>, 
 <xref rid="bib21" ref-type="bibr">21</xref>, 
 <xref rid="bib22" ref-type="bibr">22</xref>, 
 <xref rid="bib23" ref-type="bibr">23</xref>]. Thus, monitoring and characterizing the local B19V circulation can contribute to undertaking measures for safe use of blood. In Argentina, B19V epidemiology in blood banks is unknown and the screening of this agent is not routinely performed. Therefore, we aimed to determine the frequency of B19V DNA detection and the seroprevalence of B19V among local blood donors.
</p>
